THE USE OF ARYLAND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES IN THE TREATMENT OF CHRONIC AND NEUROPATHIC PAIN, MIGRAINE HEADACHES, AND URGE, STRESS AND MIXED URINARY INCONTINENCE
Details for Australian Patent Application No. 2003283646 (hide)
International Classifications
Event Publications
25 March 2004 Complete Application Filed
Priority application(s): 60/430,285 02.12.02 US
29 July 2004 Application Open to Public Inspection
Published as AU-A-2003283646
18 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003283647-Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser